Wednesday, April 01, 2026

Breast Conservation Surgery vs Mastectomy: What Surgeons Recommend Today

Breast cancer treatment has evolved significantly over the past few decades, moving from radical removal approaches to more personalized and tissue-preserving techniques. Today, surgeons no longer view breast conservation surgery (BCS) and mastectomy as competing options, but as equally effective strategies chosen based on individual patient needs.

With the growing availability of reconstructive surgery in Kolkata, patients now also have better cosmetic and psychological outcomes regardless of the surgical path they choose.

Understanding The Two Surgical Options

When faced with a breast cancer diagnosis, understanding the available surgical options is crucial for making an informed decision. Each approach is designed to effectively treat the disease while considering the patient’s long-term health, comfort, and quality of life.

What Is Breast Conservation Surgery (BCS)?

Breast conservation surgery, or lumpectomy or partial mastectomy, is a procedure that involves the removal of the tumor and a small amount of surrounding healthy tissue while preserving most of the breast.

The main objective is to remove cancer without altering the natural shape and appearance of the breast. Radiation therapy is usually administered after surgery to kill any remaining cancer cells and minimize the chances of recurrence.

What Is A Mastectomy?

Mastectomy is the removal of the whole breast tissue, and in other cases, the lymph nodes and skin around the breast. It can be done on either breast or both breasts based on the type of cancer and risk factors.

After a mastectomy, patients can choose to have breast reconstruction with the help of modern surgical procedures, such as those provided in reconstructive surgery in Kolkatta, which can help to restore the shape and symmetry of the breast.

Major Differences Between BCS And Mastectomy

The basic distinction is the degree of tissue excision. BCS leaves the majority of the breast, but a mastectomy takes away all of it.

 

FactorBreast Conservation Surgery (BCS)Mastectomy
Extent of SurgeryRemoves tumor with a small margin of healthy tissueRemoves entire breast tissue
InvasivenessLess invasiveMore extensive surgery
Cosmetic OutcomePreserves most of the natural breast shapeThe breast is removed (reconstruction may be needed)
Recovery TimeGenerally faster recoveryLonger recovery period
Radiation TherapyUsually required after surgeryMay or may not be required
Risk of RecurrenceSlightly higher local recurrence riskLower local recurrence risk
Hospital StayOften shorter or a day-care procedureMay require a longer hospital stay
SuitabilityEarly-stage cancer, smaller tumorsLarger tumors, multiple areas, or high-risk cases

Impact on Body  mage

 

 

Better preservation of body image

May impact body image (can be improved with reconstruction)                    

 

 

 

Notably, several studies indicate that both methods have equal chances of survival in the long term in early-stage breast cancer.

Eligibility Criteria: Who Can Opt For What?

Not every patient is suited for the same surgical approach, as the choice largely depends on individual clinical factors. Tumor size, stage, location, and overall health all play a crucial role in determining eligibility. Understanding who can opt for which procedure helps ensure both effective treatment and optimal long-term outcomes.

Candidates for Breast Conservation Surgery

BCS is usually prescribed to patients with:

  • Stage I or II breast cancer
  • Tumors smaller than 5 cm
  • One tumor in one area
  • No radiation therapy contraindications
  • Some cases do not have high-risk genetic mutations like BRCA

It might not apply to patients who have more than one tumor in other parts of the breast or those with advanced disease.

Candidates for Mastectomy

Mastectomy may be suggested when:

  • The tumor is huge in comparison with the size of the breast
  • It has several tumors in various quadrants
  • Cancer is metastatic (Stage III or IV)
  • The genetic risk of recurrence is high in the patient
  • Radiation therapy is not an option or choice

Moreover, other patients might opt to undergo mastectomy to have a sense of security or to alleviate the fear of recurrence.

Advancements In Breast Surgery

The current surgical advances have greatly enhanced the results, particularly in patients who want to preserve their breasts.

Oncoplastic Surgery

Among the most remarkable developments is the oncoplastic breast surgery that involves the use of both cancer resection and plastic surgery. This enables the surgeons to excise bigger tumors without altering the shape and symmetry of the breast.

This has increased the eligibility of BCS so that more women can avoid mastectomy and still have safe control of cancer.

Improved Imaging and Targeting

Modern imaging techniques have assisted surgeons in accurately identifying tumors so that they can be fully removed without damaging normal tissue. This enhances cosmetic outcomes as well as oncological safety.

Advanced Reconstruction Methods

The emergence of reconstructive surgery in Kolkatta has given patients who have undergone mastectomy the opportunity to have an immediate or delayed reconstruction with the help of implants or autologous tissue.

Reconstruction has been brought to improve psychological well-being, body image, and quality of life.

Influencing Factors of Surgical Decision-Making

The decision to use BCS or mastectomy is not only a medical choice, but a very personal one, which depends on several factors:

1. Cancer Stage and Tumor Characteristics

The main determinants include tumor size, location, and spread. BCS is more appropriate in early-stage cancers, whereas mastectomy is usually necessary in advanced cases.

2. Survival and Recurrence Outcomes

It has always been demonstrated that the survival rates are the same with BCS (including radiation) and mastectomy in the case of early-stage cancers. Nevertheless, BCS can be slightly more likely to recur locally, which can be treated.

3. Patient Preference

A major role is played by emotional and psychological factors. There are those patients who want to keep their breasts, and others opt to undergo a mastectomy to have peace of mind. Studies show fear of recurrence is a major driver for choosing mastectomy.

4. Access to Radiation Therapy

Since BCS requires post-operative radiation, access to treatment facilities can influence the decision. Patients without easy access may opt for a mastectomy.

5. Cosmetic and Quality-of-Life Concerns

BCS tends to provide superior cosmetic results and satisfaction. Nevertheless, the modern methods of reconstruction have also helped to enhance the results of mastectomy patients considerably.

What Do Surgeons Recommend Today?

Modern breast surgeons support a multidisciplinary patient-centered approach. Instead of prescribing a single solution, they consider:

  • Clinical (tumor size, stage, genetics)
  • Access to care and patient lifestyle
  • Motivational preparedness and individual interests

Surgeons are increasingly preferring breast conservation surgery in most of the early-stage cases because of its good results and quality-of-life advantages. Nevertheless, mastectomy is necessary in more complicated or risky cases.

Conclusion

The debate between breast conservation surgery and mastectomy is no longer about which is superior, but about which is most appropriate for the individual patient. Oncoplastic techniques and reconstructive surgery in Kolkata have advanced, and patients now have a choice of safer, more personalized, and cosmetically satisfying options.

 

 

This is only for your information, kindly take the advice of your doctor for medicines, exercises and so on.   

 































Labels: , , , , , ,

Thursday, November 04, 2021

Some common breast cancer myths

Some common breast cancer myths 

In Indian women, breast cancer is one of the most frequent cancers. Breast cancer accounts for roughly 14 % of all cancers in women, with the percentage being higher in urban areas than in rural India. When some breast cells begin to develop abnormally and multiply more quickly than healthy cells, a lump gets formed. Cells in the breast might go to lymph modes or other regions of the body.

But patients sometimes are caught unawares and fail to take treatment at the right time due to several myths.

Myth- breast cancer cannot be developed because there is no family history.

Fact- many women who are diagnosed with breast cancer have no family history of the disease.

Myth 1- breast cancer is incurable.

Fact- if caught early enough, it is curable.

Myth 2- breast cancer is contagious or infectious.

Fact – it is not infectious or contagious.

Myth 3- breast conservation surgery is riskier than total breast removal or mastectomy

Fact- breast conservation surgery combined with radiation therapy is just as safe as total breast removal or mastectomy.

Myth 4- every breast lump is cancerous.

Fact –every breast lump should be investigated, but not every breast lump is cancerous.

The majority of new breast lumps are benign and if you had a recent normal mammogram, that percentage is likely to be even higher.

Myth 5- men are immune to breast cancer.

Fact – men account for 1 % of all breast cancer patients. Although it is uncommon, men can develop breast cancer.

Although male breast cancer accounts for only 1 – 2% of all breast cancer cases, the incidence rate is gradually increasing. Furthermore, due to a lack of awareness and delayed diagnosis, men have a higher mortality rate from breast cancer.

Myth 6- breast cancer can be caused by stress.

Fact – there is no evidence to support a connection between stress and breast cancer. There is evidence that stress does not increase the risk of breast cancer. That is not to say that stress does not affect health. This can have significant mental and physical health benefits, but it does nothing to reduce the risk of breast cancer.

Myth 7- abortion raises the risk of developing breast cancer.

Fact- this question arises because we know that estrogen exposure is directly related to breast cancer risk and abortion disrupts the normal hormonal cycle of pregnancy. But according to research, there is no link between abortion and breast cancer.

Myth 8 – a healthy lifestyle reduces the risk of breast cancer.

Fact – while it is true that overweight postmenopausal women are at an increased risk of developing breast cancer, there is nothing a woman can do to eliminate breast cancer risk. Even after a bilateral mastectomy, women are still at risk of developing new breast cancer.

Myth 9-breast cancer risk is increased by wearing underwire bras.

Fact- although underwire bras do not increase the risk of breast cancer, it is always recommended wire-free bras. The wire may irritate the skin beneath the breast, resulting in skin breakdown. This breakdown could allow bacteria to enter the breast, resulting in infection.


In Indian women, breast cancer is one of the most frequent cancers. Breast cancer accounts for roughly 14% of all cancers in women, with the percentage being higher in urban areas than in rural India. When some breast cells begin to develop abnormally and multiply more quickly than healthy cells, a lump gets formed. Cells in the breast might go to lymph nodes or other regions of the body. But patients sometimes are caught unawares and fail to take treatment at the right time due to several myths.

https://www.thehansindia.com/life-style/some-common-breast-cancer-myths-713819

Labels: , , , , , , , , , , , ,

Friday, October 29, 2021

Novel Breast Cancer Vaccine To Go Into Clinical Trials

The Cleveland Clinic’s Lerner Research Institute is set to open clinical trials for a novel breast cancer vaccine, aimed at preventing triple-negative breast cancer. Triple-negative breast cancer is an aggressive form of breast cancer, with the poorest prognosis.

The “triple-negative” comes from the fact that the cancer is not caused by estrogen, progesterone, or the HER2 protein receptors. In healthy breast cells, estrogen and progesterone hormones “tell” cells what to do; and two out of three breast cancer diagnoses test positive for either hormone receptors. HER2 is a protein that aids cell growth; too much of it can also imply breast cancer.

The treatments for these types of cancers are hormonal therapies and HER2 targeted therapies. But for a small percentage of women who test negative for all three, neither treatment options work, and mastectomy is often the only viable solution. As a result, it accounts for a disproportionately high percentage of breast cancer fatalities and recurrences.

Moreover, African American women are twice as likely to develop the cancer. Around 70-80% of people with mutations in the BCRA1 genes which makes them predisposed to cancer risks also develop this form of breast cancer.

This is why scientists have long hoped for an option that could treat or prevent this particular form of cancer, given how difficult and deadly it is. The present vaccine trial is based on a pre-clinical study, published in Nature Medicine. Before moving into the clinical trial stage, researchers found that the vaccine was effective in preventing breast tumors in mice, and also inhibiting the growth of existing tumors.

“Long term, we are hoping that this can be a true preventive vaccine that would be administered to healthy women to prevent them from developing triple-negative breast cancer, the form of breast cancer for which we have the least effective treatments,” Dr. G. Thomas Budd, from the Cleveland Clinic, said in a press release.

Participants of the trial will include survivors of early-stage triple-negative breast cancer with a high risk of recurrence. The vaccine aims to stimulate the body’s immune system to prevent

In triple-negative breast cancers, a specific breast lactation protein (α-lactalbumin), is present post-lactation. The vaccine will aim to stimulate the immune system to pre-emptively act against the “retired” protein so that it can prevent emerging tumors from growing.

As of now, the first stage of the clinical trial will study the maximum dosage that people can receive. 18-24 tumor-free participants will receive three shots, spaced two weeks apart. Researchers say that once they figure out how much of the vaccine they can administer, they can begin to look at its effects on the immune system.

Previous studies have attempted to test breast cancer vaccines in general. Dr. Leisha Emens, from Johns Hopkins Kimmel Cancer Center, developed a vaccine that “teaches” the immune system to recognize tumors as foreign bodies and attack them. Breast cancer researchers have tried to find ways to activate the immune system much earlier in general because tumors can tend to grow unchecked by evading immune detection.

Interestingly, researchers were able to develop the mRNA technology used in the Covid19 vaccines as fast as they did, because breast cancer researchers already had their eye on it. Many vaccine trials are currently underway, and most aim to help people with existing cancers or those with a high chance of recurrence, according to the Breast Cancer Research Foundation. The present vaccine, however, is the first of its kind to specifically target triple-negative breast cancer.

“The long-term objective of this research is to determine if this vaccine can prevent breast cancer before it occurs, particularly the more aggressive forms of this disease that predominate in high-risk women,” Vincent Tuohy, the primary inventor of the vaccine, stated in a press release. Tuohy has personal equity in the company which Cleveland Clinic licensed for the vaccine’s production. The US Department of Defence is funding the trial.

 

This is only for your information, kindly take the advice of your doctor for medicines, exercises and so on.   

https://gscrochetdesigns.blogspot.com. one can see my crochet creations  
https://gseasyrecipes.blogspot.com. feel free to view for easy, simple and healthy recipes    
https://kneereplacement-stickclub.blogspot.com. for info on knee replacement

 

Labels: , , , , , , ,